ULTRA-AAGL: Ultrasonographic and Surgical Assessment of Endometriosis by AAGL 2021 Endometriosis Classification

Sponsor
Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05291624
Collaborator
(none)
500
1
12.9
38.6

Study Details

Study Description

Brief Summary

In 2021, an international consensus developed a new endometriosis classification system, called AAGL 2021 Endometriosis Classification, for scoring intraoperative surgical complexity and to examine its correlation with patient-reported pain and infertility. Until now, no study has investigated the role of AAGL 2021 Endometriosis Classification in ultrasonographic assessment of patient with endometriosis. This study aims to compare the use of the AAGL 2021 Endometriosis Classification in preoperative (at ultrasound) and intraoperative (at surgery) evaluation of patients with endometriosis.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: AAGL Endometriosis Classification score - ULTRASOUND
  • Diagnostic Test: AAGL Endometriosis Classification score - SURGERY

Study Design

Study Type:
Observational
Anticipated Enrollment :
500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Concordance Between Ultrasonographic and Surgical Assessment in Patients With Endometriosis by Using AAGL 2021 Endometriosis Classification: a Single-center Prospective Study
Anticipated Study Start Date :
Apr 1, 2022
Anticipated Primary Completion Date :
Mar 31, 2023
Anticipated Study Completion Date :
Apr 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Patients with preoperative suspicion of endometriosis

Consecutive patients undergoing ultrasonographic preoperative assessment and subsequent surgical approach for deep endometriosis

Diagnostic Test: AAGL Endometriosis Classification score - ULTRASOUND
At baseline, ultrasonographic evaluation of patients by following AAGL Endometriosis Classification

Diagnostic Test: AAGL Endometriosis Classification score - SURGERY
Within 1 month from enrollment, surgical evaluation of patients by following AAGL Endometriosis Classification

Outcome Measures

Primary Outcome Measures

  1. Reproducibility between ultrasonographic and surgical AAGL staging (minimum value: 0 points, maximum value: 111 points, higher scores mean a higher surgical complexity) [Through study completion, an average of 1 month]

  2. Comparison between total ultrasonographic and surgical AAGL staging score (minimum value: 0 points, maximum value: 111 points, higher scores mean a higher surgical complexity) [Through study completion, an average of 1 month]

Secondary Outcome Measures

  1. Comparison between ultrasonographic and surgical AAGL staging subdomains (minimum value: 0 points, maximum value: 111 points, higher scores mean a higher surgical complexity) score [Through study completion, an average of 1 month]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 55 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients with suspected endometriosis undergoing ultrasonographic preoperative evaluation.
Exclusion Criteria:
  • patients with suspected or diagnosed malignancy;

  • patients a history of colorectal surgery or a surgery for endometriosis including vaginal resection, full-thickness bowel resection or excision of a endometriotic lesion of the urinary bladder;

  • patients with previous bilateral ovariectomy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ginecologia - IRCCS Ospedale Sacro Cuore Don Calabria Negrar VR Italy 37024

Sponsors and Collaborators

  • Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Simone Ferrero, Principal Investigator, Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia
ClinicalTrials.gov Identifier:
NCT05291624
Other Study ID Numbers:
  • ULTRASOUND-AAGL2021
First Posted:
Mar 22, 2022
Last Update Posted:
Mar 22, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Simone Ferrero, Principal Investigator, Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 22, 2022